These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37256658)

  • 1. An rRNA fragment in extracellular vesicles secreted by human airway epithelial cells increases the fluoroquinolone sensitivity of
    Koeppen K; Hampton TH; Barnaby R; Roche C; Gerber SA; Goo YA; Cho BK; Vermilyea DM; Hogan DA; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2023 Jul; 325(1):L54-L65. PubMed ID: 37256658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7b-5p in vesicles secreted by human airway cells reduces biofilm formation and increases antibiotic sensitivity of
    Koeppen K; Nymon A; Barnaby R; Bashor L; Li Z; Hampton TH; Liefeld AE; Kolling FW; LaCroix IS; Gerber SA; Hogan DA; Kasetty S; Nadell CD; Stanton BA
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260396
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracellular vesicles secreted by primary human bronchial epithelial cells reduce
    Sarkar S; Barnaby R; Nymon AB; Taatjes DJ; Kelley TJ; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L164-L174. PubMed ID: 38084406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.
    Millar BC; McCaughan J; Rendall JC; Moore JE
    Clin Respir J; 2021 Jan; 15(1):116-120. PubMed ID: 32790958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor.
    Adabi M; Talebi-Taher M; Arbabi L; Afshar M; Fathizadeh S; Minaeian S; Moghadam-Maragheh N; Majidpour A
    Infect Chemother; 2015 Jun; 47(2):98-104. PubMed ID: 26157587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor.
    Tohidpour A; Najar Peerayeh S; Mehrabadi JF; Rezaei Yazdi H
    Curr Microbiol; 2009 Sep; 59(3):352-5. PubMed ID: 19554368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.
    Zhao L; Wang S; Li X; He X; Jian L
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):124. PubMed ID: 32758289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
    Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
    Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
    Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P; Izard D; Mullié C
    Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant
    Dhiman S; Ramirez D; Li Y; Kumar A; Arthur G; Schweizer F
    ACS Infect Dis; 2023 Apr; 9(4):864-885. PubMed ID: 36917096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fis Contributes to Resistance of Pseudomonas aeruginosa to Ciprofloxacin by Regulating Pyocin Synthesis.
    Long Y; Fu W; Wang S; Deng X; Jin Y; Bai F; Cheng Z; Wu W
    J Bacteriol; 2020 May; 202(11):. PubMed ID: 32205461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem.
    Rehman A; Patrick WM; Lamont IL
    J Med Microbiol; 2019 Jan; 68(1):1-10. PubMed ID: 30605076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study.
    Gómez-Junyent J; Rigo-Bonnin R; Benavent E; Soldevila L; Padullés A; Cabo X; Tubau F; Ariza J; Murillo O
    Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):587-599. PubMed ID: 32440843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
    Al-Obaidi H; Kalgudi R; Zariwala MG
    Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
    J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
    Rees VE; Yadav R; Rogers KE; Bulitta JB; Wirth V; Oliver A; Boyce JD; Peleg AY; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.